On May 30, 2025, Apimeds Pharmaceuticals US, Inc. appointed Erick J. Frim as Chief Financial Officer, succeeding Mark Corrao; Frim has extensive experience in financial management. The company has entered a consulting agreement with him, paying $2,500 monthly for up to eight hours of service plus $250 for additional hours.